Spots Global Cancer Trial Database for impaired glucose tolerance
Every month we try and update this database with for impaired glucose tolerance cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma | NCT05873322 | Precursor Cell ... Drug-Induced Di... Impaired Glucos... Lymphoma | 1 Year - 17 Years | Aarhus University Hospital | ||
Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma | NCT05873322 | Precursor Cell ... Drug-Induced Di... Impaired Glucos... Lymphoma | 1 Year - 17 Years | Aarhus University Hospital | ||
Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) | NCT04373265 | Adrenocortical ... | Relacorilant Pembrolizumab | 18 Years - | Corcept Therapeutics |